Themis Medicare Other Announcement

Themis Medicare Board Meeting Date

Themis Medicare's board is scheduled for November 5, 2026, to approve quarterly and half-year financial results. The trading window remains closed until 48 hours post-results publication.

Themis Medicare Share Pledge

Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.

Value

₹135.0 Cr

Themis Medicare Management Change

Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.

Themis Medicare Annual General Meeting

Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.

Themis Medicare Other Announcement

Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).

Themis Medicare Credit Rating

CARE Ratings downgraded Themis Medicare's long-term and short-term bank facility ratings. The downgrade reflects deteriorating profitability, heightened competition, and weak debt coverage indicators.

Mahindra & Mahindra Financial Services Other Announcement

Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.

ACME Solar Holdings Other Announcement

ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.

eMudhra Other Announcement

eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.

Sagarsoft (India) Other Announcement

Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.

Sadhana Nitro Chem Other Announcement

Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.